• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[采用定量方法评估急性肺炎、慢性支气管炎和支气管哮喘的严重程度及动态变化的结果]

[Results using a quantitative method for evaluating the severity and dynamics of acute pneumonia, chronic bronchitis and bronchial asthma].

作者信息

Marchuk G I, Berbentsova E P

出版信息

Ter Arkh. 1986;58(3):63-70.

PMID:3715733
Abstract

The authors describe the results of application during 6 months of a quantitative method involving the use of the clinical and laboratory indicators of the disease gravity in routine medical work, which included correction of the therapeutic tactics as regards the immunological characteristics in 668 patients with acute pneumonia, 1100 with chronic bronchitis, and 120 with bronchial asthma. The use of the indicators of the disease gravity made it possible to objectively evaluate the gravity and the time-course of the diseases under consideration, to decide on the etiological treatment, to control the treatment efficacy and make necessary corrections, to specify the time of administration and withdrawal of biological stimulation, as well as to define the time of convalescence or remission. The authors have developed indications and specified contraindications as to the use of passive immunization and biological (immunocorrective) stimulation in the management of acute pneumonia.

摘要

作者描述了一种定量方法在6个月应用期间的结果,该方法涉及在日常医疗工作中使用疾病严重程度的临床和实验室指标,其中包括针对668例急性肺炎患者、1100例慢性支气管炎患者和120例支气管哮喘患者的免疫特征对治疗策略进行调整。使用疾病严重程度指标能够客观评估所研究疾病的严重程度和病程,决定病因治疗,控制治疗效果并进行必要的调整,明确生物刺激的给药和停药时间,以及确定康复或缓解时间。作者制定了关于在急性肺炎治疗中使用被动免疫和生物(免疫纠正)刺激的适应证和明确的禁忌证。

相似文献

1
[Results using a quantitative method for evaluating the severity and dynamics of acute pneumonia, chronic bronchitis and bronchial asthma].[采用定量方法评估急性肺炎、慢性支气管炎和支气管哮喘的严重程度及动态变化的结果]
Ter Arkh. 1986;58(3):63-70.
2
[C-reactive protein, SR and white blood cell count in acute lower respiratory tract diseases. The usefulness of blood tests in diagnosis of pneumonia].
Tidsskr Nor Laegeforen. 1991 Aug 10;111(18):2249-52.
3
Analysis of proteolytic enzymes and their natural inhibitors in serum and bronchial lavage fluid in atopic bronchial asthma, chronic bronchitis and pneumonia.特应性支气管哮喘、慢性支气管炎和肺炎患者血清及支气管灌洗液中蛋白水解酶及其天然抑制剂的分析
Allerg Immunol (Leipz). 1985;31(3):169-78.
4
[Metabolic aspects of the differential diagnosis of chronic asthmatic bronchitis and bronchial asthma].[慢性喘息性支气管炎与支气管哮喘鉴别诊断的代谢方面]
Ter Arkh. 1986;58(12):12-4.
5
[Acid-soluble fractions of the blood in patients with nonspecific diseases of the respiratory organs].[呼吸器官非特异性疾病患者血液中的酸溶性成分]
Lab Delo. 1991(8):24-7.
6
[Respiratory infection in patients with bronchial asthma. Clinicolaboratory characteristics].[支气管哮喘患者的呼吸道感染。临床实验室特征]
Ter Arkh. 2006;78(3):35-9.
7
[Comparative evaluation of the erythrocyte sedimentation rate and sigma-ESR methods in diagnosing acute pneumonia and chronic bronchitis].红细胞沉降率与西格玛红细胞沉降率方法在诊断急性肺炎和慢性支气管炎中的比较评估
Vrach Delo. 1986 Aug(8):49-50.
8
[The level of plasma fibrinogen and C-reactive protein in patients with acute and chronic pneumonia].[急性和慢性肺炎患者的血浆纤维蛋白原和C反应蛋白水平]
Sov Med. 1966 Apr;29(4):120-2.
9
[The treatment of patients with nonspecific inflammatory lung diseases under outpatient conditions].[门诊条件下非特异性炎性肺病患者的治疗]
Vrach Delo. 1989 Jun(6):70-3.
10
[A comparative assessment of the clinical efficacy of standard and low-volume plasmapheresis in treating patients with bronchial asthma and chronic bronchitis].[标准体积与小体积血浆置换术治疗支气管哮喘和慢性支气管炎患者的临床疗效比较评估]
Ter Arkh. 1996;68(12):28-30.